| Business Name: |
Stemedica Cell Technology |
| Contact Person: |
Roger Howe, Manager |
| Address: |
5375 Mira Sorrento Place # 100, San Diego, California 92121 |
| Phone Number: |
(858) 658-0910 |
| Website Address: |
stemedica.com |
| Annual Revenue (USD): |
Unknown |
| Founding Year: |
2005 |
| Location Type: |
Single Location |
| Employee Number: |
1 to 4 |
| Business Type: |
B2B (Business to Business) |
| Business Category: |
Commercial Medical Research |
| SIC Code: |
8731 |
| NAICS Code: |
5417114 |
| Share This Business: |
|
| Related Businesses: |
Medivas LLC - San Diego, CA 92121
Acea Biosciences Inc - San Diego, CA 92121
Bio-Quant Inc - San Diego, CA 92121
Cylene Pharmaceuticals - San Diego, CA 92121
Krex Pharmaceuticals Inc - San Diego, CA 92121
Advanced Biodelivery Sciences - San Diego, CA 92121
S K S Ocular LLC - San Diego, CA 92121
Tenova Pharmaceuticals Inc - San Diego, CA 92121
Gnf Commercial Systems - San Diego, CA 92121
Sage Bioventures Inc - San Diego, CA 92121
Rempex Pharmaceuticals Inc - San Diego, CA 92121
Biomedica Inc - San Diego, CA 92121
Helicon Therapeutics - San Diego, CA 92121
Celgene Research San Diego - San Diego, CA 92121
Targegen Inc - San Diego, CA 92121
Astute Medical Inc - San Diego, CA 92121
|
The company Stemedica Cell Technology provides B2B services in the form of Commercial Medical Research from its single location in California.
1 to 4 employees work for Stemedica Cell Technology, and the business now earns Unknown per annum.
Stemedica Cell Technology was launched in 2005 and is classified under SIC code and category 8731 , and NAICS number and grouping 5417114 .
To contact Stemedica Cell Technology, please call Roger Howe, Manager with the phone number (858) 658-0910 or visit its single location at 5375 Mira Sorrento Place # 100 in San Diego, California 92121.
The location of the single location can also be found using the coordinates 32.892359,-117.206555.
Read more details about this business on the webpage stemedica.com or follow the company’s social media accounts, on Twitter and on Facebook.